Alan McFarlane

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.

abrdn Alternative Investments Ltd. (AAI) is the wholly owned asset management subsidiary of Aberdeen Asset Investment Group Ltd. and their ultimate parent is abrdn Plc (LON: ABDN, ADR: SLFPF) in Great Britain. Formerly held by Lloyds Banking Group plc (LSE: LLOY), Aberdeen Asset Management plc entered into a strategic alliance with Lloyds Banking Group plc in 2013, acquiring AAI and their related private equity and infrastructure fund management businesses. Formerly known as Aberdeen Asset Investments Ltd., the firm was founded in 1964 and is headquartered in London. AAI provides investment solutions to private individuals, financial institutions, charities, investment trusts and corporate and local government pension funds in Great Britain and worldwide.

Aegon Asset Management UK PLC (Aegon AM UK) is the asset management subsidiary of Aegon Asset Management UK Holdings Ltd., ultimately owned by AEGON NV (AMS: AGN) in The Netherlands. The firm's roots date to 1831 when the Scottish Equitable Life Assurance Society was established. In 1994, Scottish Equitable sold a significant minority stake to Aegon NV, becoming a wholly-owned subsidiary in 1998. In 2001, the firm was re-branded as AEGON Asset Management and changed their name to Kames Capital in 2011. They became Aegon Asset Management UK PLC in 2020. Headquartered in Edinburgh, Aegon AM UK manages assets on behalf of clients internationally, which includes public funds, pension plans, financial institutions, endowments, foundations, wealth managers, family offices and individuals. The firm is a signatory to the United Nations Principles for Responsible Investment (UNPRI).

Edinburgh Partners Ltd. is a directly owned, UK-based investment management subsidiary of Franklin Resources, Inc. (NYSE: BEN) in the US. The firm was founded by Alasdair Nairn as DMWS 612 Ltd. in 2003 to exclusively focus on investment research and portfolio management. Headquartered in Edinburgh, Edinburgh Partners provides investment advisory services for institutional clients, which includes public and corporate pensions, registered investment companies, pooled investment vehicles and sub-advisory accounts.

New Vantage Group LLC (New Vantage Group) is a venture capital firm founded in 1997 by John A. May. The firm is headquartered in McLean, Virginia.

Saracen Fund Managers Ltd. (Saracen) is a boutique fund management firm headquartered in Edinburgh, UK. The firm was founded in 1997 and is a subsidiary of AssetCo Plc (LON: ASTO). Saracen manages funds for a range of clients including UK and international retail investors and institutions.

Aubrey Capital Management Ltd. (ACM) is an investment management firm headquartered in Edinburgh, UK with additional office in London. The firm was founded in 2006 as DMWS 767 Ltd. They are a subsidiary of Treetop Asset Management SA in Luxembourg. ACM provides discretionary investment services for private individuals, family groups, trusts, charities and pensions.

MASA Life Science Ventures (MASA Life Science Venture) is a venture capital firm founded in 1994 by Andrew Sinclair Dunlop. The firm is headquartered in Bethesda, Maryland.

Center for Strategic & International Studies, Inc. provides strategic insights & policy solutions to decision makers in government, international institutions, the private sector, and civil society. Its projects focus on areas such as AIDS, arms control, conflict resolution, NATO, the environment, immigration, intelligence, trade, health care, OPEC, space policy, and terrorism. The company was founded in 1962 by David M. Abshire and Admiral Arleigh Burke and is headquartered in Washington, DC.

Cantor Fitzgerald Asset Management Europe (CFAME) is an investment management firm headquartered in Dublin, Ireland. Formerly known as Merrion Capital Investment Managers Ltd., the firm was founded in 1986 and was acquired in 2018 by Cantor Fitzgerald Ireland Ltd., which is owned by Cantor Fitzgerald LP in the US. CFAME manages a range of investment funds and portfolios on behalf of institutional, corporate, non-profit clients and high-net-worth individuals.

Midmar Capital LLP is a privately-owned alternative investment firm headquartered in Edinburgh, UK. The firm was founded in 2010 by John Gallacher, James Nicol and Alistair MacDonald. Midmar Capital provides regulatory incubation and support services for start-up investment businesses with a focus upon alternative assets such as private equity, venture capital and hedge funds.

Balhousie Care Ltd. is a provides and operates residential care homes in Scotland. The company was founded by Tony Banks in 1991 and is headquartered in Scotland, the United Kingdom.

Inspiring Scotland engages in dealing and solving social problems for its people and communities. The company was founded by Helen Chambers in 2008 and is headquartered in Scotland, the United Kingdom.

Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland.

SIRAKOSS Ltd. develops medical devices. It focuses on synthetic Bone technology. The company was founded in October 2010 by Jordan Christopher Conway, Janet Mabel Scott Gibson, and Iain Ronald Gibson and is headquartered in Aberdeen, the United Kingdom.

Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom.

Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom.

The Royal Edinburgh Military Tattoo Ltd. operates as a performing arts company. The Royal Edinburgh Military Tattoo Ltd. is based in Edinburgh, UK, and has subsidiaries in the UK. The British company was founded in 1990, and Jason Barrett has been the CEO of the company since 2023.